Isomorphic inks deals with Eli Lilly and Novartis for drug discovery

Isomorphic Labs, the drug discovery-focused spin-off of Google's DeepMind division, has landed deals with pharma companies worth ~$3 billion.

Artificial Intelligence https://ift.tt/TSgPsDE
AI Transformations